This study evaluates the ability of MIL-based artificial intelligence models to detect mutations in the TP53 gene from digital slides at different magnification levels. The results indicate very limited performance at 5x, a notable improvement at 10x and 20x, but even so, mutation detection remains below the accuracy achieved in tumor identification tasks.
In detail, models based on Multiple Instance Learning show that signals associated with point mutations such as TP53 are difficult to capture when spatial resolution is low. At 5x, morphological information is insufficient and background noise overcomes the biological signal. At 10x and 20x, more detectable features appear, but the ability to discriminate mutated cells remains limited by tissue heterogeneity and the infrequent distribution of mutations within the sample.
Among the factors limiting success are slide sampling, noise in image data, and the spatial rarity of mutations. The sampling method can introduce biases if the selected regions do not represent tumor heterogeneity. Noise can come from variations in staining, digitization, and technical artifacts. The scarcity of mutated instances within a digital slide makes slide-level labels weak for learning robust signals.
The practical implications are clear. Although artificial intelligence offers new avenues for histopathological analysis, detecting specific mutations such as TP53 from digital images remains a challenge. Models require better-sampled data, finer annotations, and learning techniques that can handle highly dispersed signals and high noise. Integrating multimodal data such as sequencing and clinical metadata may be key to improving accuracy.
At Q2BSTUDIO, we specialize in turning these challenges into solutions. As a custom software and application development company, we offer custom software and custom applications projects that integrate artificial intelligence models tailored to clinical and research requirements. Our team combines expertise in MIL modeling, digital image processing, and robust architectures for healthcare environments.
Our services include consulting and development of solutions that incorporate cybersecurity best practices and regulatory compliance, scalable deployments on aws and azure cloud services, and pipelines to manage data quality and traceability. We also offer business intelligence services and dashboards with power bi to visualize results and support clinical and operational decision-making.
For companies seeking to transform data into value, we offer ai for business solutions, creation of custom AI agents, and development of explainable models that facilitate clinical interpretation. Our experience in applied artificial intelligence allows us to design workflows that reduce noise, optimize sampling, and improve the available signal for molecular detection tasks from images.
In summary, detecting TP53 mutations in digital slides remains complex due to technical and biological limitations. The combination of better sampling, higher-resolution annotations, advanced models, and multimodal data integration is the most promising path. Q2BSTUDIO can accompany your organization at every step, from developing custom software and custom applications to secure deployment on aws and azure cloud services, with cybersecurity solutions, business intelligence services, AI agents, ai for business, and power bi dashboards to maximize the impact of artificial intelligence on your project.
